Clinical meaning
Acute interstitial nephritis (AIN) is an immune-mediated inflammatory condition affecting the renal interstitium and tubules, representing approximately 15-27% of all cases of acute kidney injury (AKI) requiring biopsy. The hallmark of AIN is inflammatory cell infiltration of the renal interstitium with tubular damage in the absence of primary glomerular or vascular pathology. The most common cause is drug hypersensitivity (accounting for 70-75% of cases), followed by autoimmune conditions (10-15%) and infections (5-10%). The registered nurse plays a critical role in identifying the offending agent, monitoring renal function trends, and managing the supportive care required during the recovery period.
Drug-induced AIN is a type IV (delayed-type) hypersensitivity reaction mediated by T-lymphocytes rather than antibodies. When a drug or its metabolite acts as a hapten (a small molecule that alone cannot trigger an immune response), it binds to renal tubular proteins, forming a hapten-carrier complex that is processed and presented by antigen-presenting cells (dendritic cells, macrophages) to T-helper lymphocytes via MHC class II molecules. The activated T-cells release pro-inflammatory cytokines (interferon-gamma, interleukin-2, tumor necrosis factor-alpha) that recruit additional inflammatory cells -- cytotoxic T-lymphocytes, monocytes/macrophages, and eosinophils -- to the renal interstitium. These inflammatory cells directly damage tubular epithelial cells through cytotoxic mechanisms and further amplify the inflammatory response.
The interstitial inflammation causes edema of the renal parenchyma, which compresses the peritubular capillaries and reduces renal blood flow at the microvascular level. The damaged tubular cells lose their ability to concentrate urine (loss of medullary concentration gradient), reabsorb sodium (causing sodium wasting), secrete potassium and hydrogen ions (causing hyperkalemia and metabolic acidosis), and reabsorb low-molecular-weight proteins (causing tubular proteinuria). The combination of interstitial edema, peritubular capillary compression, and tubular dysfunction produces the clinical picture of AKI with rising serum creatinine and decreasing urine output.